How reliable are left ventricular ejection fraction cut offs assessed by echocardiography for clinical decision making in patients with heart failure?

International Journal of Cardiovascular Imaging

Volumn 29, Issue 3, 2013, Pages 581-588

  Kaufmann, Beat A ^a   Min, Son Y ^a   Goetschalckx, Kaatje ^a   Bernheim, Alain M ^a   Buser, Peter T ^a   Pfisterer, Matthias E ^a   Brunner La Rocca, Hans Peter ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical decision making; Device therapy; Heart failure; Left ventricular ejection fraction; Variability

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; QRS COMPLEX; RELIABILITY; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DECISION SUPPORT TECHNIQUES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; GERMANY; HEART FAILURE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; NATRIURETIC PEPTIDE, BRAIN; OBSERVER VARIATION; PATIENT SELECTION; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; STROKE VOLUME; SWITZERLAND; VENTRICULAR FUNCTION, LEFT;

EID: 84877845970     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-012-0122-5     Document Type: Article

References (25)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877-883
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225-237
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150
4. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) Focused update incorporated into the acc/aha 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American college of cardiology foundation/american heart association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation 119:e391-e479
5. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K (2008) Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the heart failure association of the esc (hfa) and endorsed by the European society of intensive care medicine (esicm). Eur Heart J 29:2388-2442
6. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ (1987) Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76:44-51
7. Wong M, Johnson G, Shabetai R, Hughes V, Bhat G, Lopez B, Cohn JN (1993) Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans affairs cooperative studies v-heft i and ii. V-heft va cooperative studies group. Circulation 87:VI65-VI70
8. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/new zealand heart failure research collaborative group. Lancet (1997) 349:375-380
9. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The solvd investigators. N Engl J Med (1991) 325:293-302
10. Effects of metoprolol cr in patients with ischemic and dilated cardiomyopathy: the randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation (2000) 101:378-384
11. Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, Faletra FF, Franke A, Hung J, de Isla LP, Kamp O, Kasprzak JD, Lancellotti P, Marwick TH, McCulloch ML, Monaghan MJ, Nihoyannopoulos P, Pandian NG, Pellikka PA, Pepi M, Roberson DA, Shernan SK, Shirali GS, Sugeng L, Ten Cate FJ, Vannan MA, Zamorano JL, Zoghbi WA (2012) Eae/ase recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr 25:3-46
12. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP (2009) Bnp-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (time-chf) randomized trial. JAMA 301:383-392
13. Brunner-La Rocca HP, Buser PT, Schindler R, Bernheim A, Rickenbacher P, Pfisterer M (2006) Management of elderly patients with congestive heart failure - design of the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (time-chf). Am Heart J 151:949-955
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr 18:1440-1463
15. Tighe DA, Rosetti M, Vinch CS, Chandok D, Muldoon D, Wiggin B, Dahlberg ST, Aurigemma GP (2007) Influence of image quality on the accuracy of real time three-dimensional echocardiography to measure left ventricular volumes in unselected patients: a comparison with gated-spect imaging. Echocardiography 24:1073-1080
16. Erbel R, Schweizer P, Lambertz H, Henn G, Meyer J, Krebs W, Effert S (1983) Echoventriculography - a simultaneous analysis of two-dimensional echocardiography and cineventriculography. Circulation 67:205-215
17. Schalla S, Nagel E, Lehmkuhl H, Klein C, Bornstedt A, Schnackenburg B, Schneider U, Fleck E (2001) Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol 87:95-99
18. Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, Pennell DJ (2000) Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 21:1387-1396
19. Chuang ML, Hibberd MG, Salton CJ, Beaudin RA, Riley MF, Parker RA, Douglas PS, Manning WJ (2000) Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. J Am Coll Cardiol 35:477-484
20. Hoffmann R, von Bardeleben S, ten Cate F, Borges AC, Kasprzak J, Firschke C, Lafitte S, Al-Saadi N, Kuntz-Hehner S, Engelhardt M, Becher H, Vanoverschelde JL (2005) Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J 26:607-616
21. Whalley GA, Gamble GD, Walsh HJ, Wright SP, Agewall S, Sharpe N, Doughty RN (2004) Effect of tissue harmonic imaging and contrast upon between observer and test-retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure. Eur J Heart Fail 6:85-93
22. Shahgaldi K, Gudmundsson P, Manouras A, Brodin LA, Winter R (2009) Visually estimated ejection fraction by two dimensional and triplane echocardiography is closely correlated with quantitative ejection fraction by real-time three dimensional echocardiography. Cardiovasc Ultrasound 7:41
23. Cannesson M, Tanabe M, Suffoletto MS, McNamara DM, Madan S, Lacomis JM, Gorcsan J III (2007) A novel two-dimensional echocardiographic image analysis system using artificial intelligence-learned pattern recognition for rapid automated ejection fraction. J Am Coll Cardiol 49:217-226
24. Ray SG, Metcalfe MJ, Oldroyd KG, Pye M, Martin W, Christie J, Dargie HJ, Cobbe SM (1995) Do radionuclide and echocardiographic techniques give a universal cut off value for left ventricular ejection fraction that can be used to select patients for treatment with ace inhibitors after myocardial infarction? Br Heart J 73:466-469
25. Jenkins C, Bricknell K, Hanekom L, Marwick TH (2004) Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol 44:878-886